| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT05645692 | A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT… | Urothelial Cancer | Active, Not Recruiting |
| NCT05805501 | A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With… | Renal Cell Carcinoma | Active, Not Recruiting |
| NCT05775289 | A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus… | Non-small Cell Lung Cancer | Active, Not Recruiting |
| NCT05852691 | A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in… | Breast Cancer | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT04524871 | A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment… | Advanced Liver Cancers | Recruiting |
| NCT04140500 | Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or… | Solid Tumors | Active, Not Recruiting |